Focus Partners Wealth’s Sana Biotechnology SANA Stock Holding History

Focus Partners Wealth’s Portfolio SANA Stock Details SANA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$145K	Sell	41,555 -2,139	-5%	-$6.89K	﹤0.01%	2571
2026 Q1	$126K	Buy	43,694 +1,538	+4%	+$6.06K	﹤0.01%	2491
2025 Q4	$172K	Buy	42,156 +11,449	+37%	+$51.3K	﹤0.01%	2468
2025 Q3	$109K	Buy	30,707 +388	+1%	+$1.4K	﹤0.01%	2123
2025 Q2	$82.8K	Buy	30,319 +4,994	+20%	+$10.3K	﹤0.01%	1955
2025 Q1	$42.5K	Buy	25,325 +3,949	+18%	+$11K	﹤0.01%	1851
2024 Q4	$34.8K	Buy	+21,376	New	+$63.7K	﹤0.01%	1831
2024 Q3	–	Sell	-41,952	Closed	-$248K	–	1695
2024 Q2	$248K	Buy	41,952 +22,309	+114%	+$178K	﹤0.01%	1115
2024 Q1	$196K	Buy	+19,643	New	+$147K	﹤0.01%	942

Other funds holding SANA

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Flagship Pioneering Cambridge, Massachusetts $1.54B AUM 86.39% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Marex Group London $23.6B AUM 57.16% 1-Year Est. Return

Focus Partners Wealth's SANA Position: Q2 2026 in Review

Focus Partners Wealth reduced its Sana Biotechnology (SANA) stake by 4.9% in Q2 2026, selling an estimated $6.89K and leaving 41,555 shares worth $145K. The position accounts for ﹤0.01% of the portfolio, ranked #2571.

Focus Partners Wealth first reported a position in SANA in Q1 2024 and has held it in 9 quarters since. The position peaked at $248K in Q2 2024. 211 funds tracked by Wall St. Rank hold SANA as of Q2 2026.

Focus Partners Wealth held 41,555 shares of Sana Biotechnology worth $145K as of Q2 2026.
Focus Partners Wealth sold 2,139 Sana Biotechnology shares in Q2 2026, an estimated $6.89K.
Sana Biotechnology made up ﹤0.01% of Focus Partners Wealth's portfolio in Q2 2026, its #2571 holding.
Focus Partners Wealth first reported a position in Sana Biotechnology in Q1 2024 and has held it in 9 quarters since.
Focus Partners Wealth's Sana Biotechnology position peaked at $248K in Q2 2024.
211 funds tracked by Wall St. Rank held Sana Biotechnology as of Q2 2026.

Based on Focus Partners Wealth's 13F filing for Q2 2026, filed 12 Aug 2026.